Bret Taback, MD
About Bret Taback, MD:
Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital.
During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon’s Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor.
Expertise:
Honors:
Member, International Scientific Committee, The 4th International Sentinel Node Congress, Los Angeles, CA (2004)
Co-Chairman, The 3rd International Conference on Circulating Nucleic Acids in Plasma and Serum & Serum Proteomics (CNAPS III), Santa Monica, CA (2003)
Young Investigator Award, The 3rd International Sentinel Node Congress, Yokohama, Japan (2002)
Merit Award, American Society of Clinical Oncology, Orlando, FL (2002)
Elected to Associate Member Council, American Association for Cancer Research, Philadelphia, PA (2001-2004)
Scholarship Award to attend Epidemiology and Biostatistics Conference, Berlex Oncology Foundation, Hackensack, NJ (2001)
Joyce Eisenberg-Keefer Fellowship Award, Santa Monica, CA (2000)
Merit Award, American Society of Clinical Oncology, New Orleans, LA (2000)
Interests:
Appointments:
Education:
New Patients:
Locations
Primary Locations:
CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
- For new and current patient appointments, call:
- (212) 305-9676
- Fax:
- (212) 305-1522
Insurances:
Please contact the doctor's office directly to verify that your particular insurance is accepted.
Publications:
Fine RE, Gilmore RC, Tomkovich KR, Dietz JR, Berry MP, Hernandez LE, Columbus KS, Seedman SA, Fisher CS, Han LK, Manahan ER, Hicks RD, Vaidya RP, Curcio LD, Sevrukov AB, Kenler AS, Taback B, Chen M, Miller ME, Gold L, Anglin BV, Aoun HD, Simmons RM, Feldman SM, Boolbol SK. Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Ann Surg Oncol. 2024 Oct;31(11):7273-7283. doi: 10.1245/s10434-024-16181-0. Epub 2024 Sep 16.PMID: 39283572
Reyes A, Sun L, Ha R, Desperito E, Brown M, Francescone MA, Ugras S, Wiechmann L, Rao R, Taback B. A Comprehensive Assessment of Radial Scars on Core Needle Biopsy in Patients with or Without Breast Cancer: Upgrade Rate and Implications on Management. Clin Breast Cancer 2024 Jun;24(4):e273-e278. doi: 10.1016/j.clbc.2024.01.020. Epub 2024 Feb 1. PMID: 38402106.
Levy AS, Murphy AI, Ishtihar S, Peysakhovich A, Taback B, Grant RT, Ascherman JA, Feldman S, Rohde CH. Lymphatic microsurgical preventive healing approach for the primary prevention of lymphedema: A 4-year follow-up. Plast Reconstr Surg. 2023 Feb 1;151(2):413-420
Mojahed D, Applegate M, Guo H, Taback B, Ha R, Hibshoosh H, Hendon C. Optical coherence tomography holds promise to transform the diagnostic anatomic pathology gross evaluation process. J Biomed Opt. 2022 Sep;27(9):096003
Brown A, Buss EJ, Chin C, Liu G, Lee S, Rao R, Taback B, Wiechmann L, Horowitz D, Choi JC, Katz LM, Connolly EP. Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Study. Front Oncol. 2022 Jun 29;12:788213
Cogan JC, Accordino MK, Beauchemin MP, Spivack JH, Ulene SR, Elkin EB, Melamed A, Taback B, Wright JD, Hershman DL. Efficacy of a password-protected, pill-dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery. Cancer. 2022 Sep 15;128(18):3392-3399
Koelmeyer LA, Gaitatzis K, Dietrich MS, Shah CS, Boyages J, McLaughlin SA, Taback B, Stolldorf DP, Elder E, Hughes TM, French JR, Ngui N, Hsu JM, Moore A, Ridner SH: Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer. 2022 Sep 15;128(18):3408-3415
Iwai Y, Prigoff J, Sun L, Wiechmann, L, Taback B, Rao R, Ugras SK: Shaves off the Cavity or Specimen in Lumpectomy for Breast Cancer. J Surg Res. 2022 Sep; 277:296-302
Lifrieri A, Fuzesi S, Desperito E, Taback B: When the clipped node goes missing, CT guided SAVI SCOUT placement: A novel approach for localizing soft tissue targets. Clin Imaging. 2022 May;85:115-117
Wu V, Colquhoun M, Fuzesi S, Sun L, Ugras S, Wiechmann L, Rao R, Taback B, Omitting Sentinel Lymph Node Biopsy in Postmenopausal Hormone Receptor Positive Stage I Breast Cancer has no Adverse Impact on Outcomes or Regional Recurrence Despite Current Predictors of Nodal Positivity. Ann Surg Oncol Vol 22. 2022 (suppl 1: abstract E35)